δ-Aminolaevulinic acid-induced photodynamic therapy inhibits protoporphyrin IX biosynthesis and reduces subsequent treatment efficacy in vitro by Gibson, S L et al.
Photodynamic therapy (PDT) has been used successfully to
control the growth of a variety of human malignancies (Rosenthal
and Glatstein, 1994; van Hillegersberg et al, 1994; Fisher et al,
1995; Kriegmeir et al, 1996; Peng et al, 1997). Based on these
clinical trials, PDT has been approved as a treatment for various
cancers in the US, Canada, France, The Netherlands and Japan.
Traditionally, PDT consists of the systemic, topical or intra-
tumoural administration of a photosensitizer, followed by a time
interval to allow dye distribution and localization. Malignant
lesions are then exposed to the light of an appropriate photosensi-
tizer absorption wavelength. Photoactivation of the dye results in
the formation of reactive oxygen species of which singlet oxygen
(1O2) is reported to be the major species and the one primarily
responsible for the ensuing toxicity. Photofrin®, a derivative of
haematoporphyrin, is currently the photosensitizer that has
received approval for PDT.
There are numerous ongoing studies aimed at development of
‘new generation’ photosensitizers, and many of these compounds
show promise (Gomer, 1991; Pandey et al, 1995; Fan et al, 1997).
Recently, there has been considerable interest in the formation
of an endogenously produced photosensitizer, protoporphyrin IX
(PPIX) (Malik and Lugaci, 1987; Kennedy and Pottier, 1992; Peng
et al, 1997). Protoporphyrin IX is formed as the penultimate step
of the haem biosynthetic pathway. The promise of this photosensi-
tizer stems from reports that PPIX accumulates to a greater extent
in malignant compared to normal tissue after administration of
d-aminolaevulinic acid (d-ALA) (Dailey and Smith, 1984; van
Hillegersberg et al, 1992; Malik et al, 1995). Although the basis
for its concentration in tumour tissue is not known, this observa-
tion is being exploited in the use of d-ALA in PDT.
Earlier, we demonstrated that retreatment of R3230AC rat
mammary adenocarcinomas that had recurred after an initial course
of PDT using Photofrin® as the photosensitizer was as effective in
controlling tumour growth as the original course of therapy. Here,
as an extension of those earlier studies, we have directed our efforts
towards defining the effects that exogenous d-ALA administration
and subsequent photosensitization would produce on the enzymes
in the haem biosynthetic pathway. The administration of d-ALA
circumvents the initial biosynthetic regulatory step, d-ALA
synthase (d-ALA-S), which is feedback inhibited by haem.
Presumably, this subversion of regulation facilitates the intra-
cellular accumulation of PPIX after d-ALA administration (Dailey
and Smith, 1984; Batlle, 1993). It is inferred that the second
slowest step in the haem biosynthetic pathway, porphobilinogen
deaminase (PBGD) (Healey et al, 1981; Ades, 1990), would be the
next rate-limiting step after d-ALA-S is circumvented. In a recent
report, we demonstrated a relationship between PBGD activity and
the amount of PPIX accumulated, both of which increased in the
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Summary Recently, considerable interest has been given to photodynamic therapy of cancer using d-aminolaevulinic acid to induce
protoporphyrin IX as the cell photosensitizer. One advantage of this modality is that protoporphyrin IX is cleared from tissue within 24 h after
d-aminolaevulinic acid administration. This could allow for multiple treatment regimens because of little concern regarding the accumulation
of the photosensitizer in normal tissues. However, the haem biosynthetic pathway would have to be fully functional after the first course of
therapy to allow for subsequent treatments. Photosensitization of cultured R3230AC rat mammary adenocarcinoma cells with d-
aminolaevulinic acid-induced protoporphyrin IX resulted in the inhibition of porphobilinogen deaminase, an enzyme in the haem biosynthetic
pathway, and a concomitant decrease in protoporphyrin IX levels. Cultured R3230AC cells exposed to 0.5 mM d-aminolaevulinic acid for 27 h
accumulated 6.07 ´ 10–16 mol of protoporphyrin IX per cell and had a porphobilinogen deaminase activity of 0.046 fmol uroporphyrin per
30 min per cell. Cells cultured under the same incubation conditions but exposed to 30 mJ cm–2 irradiation after a 3-h incubation with d-
aminolaevulinic acid showed a significant reduction in protoporphyrin IX, 2.28 ´ 10–16 mol per cell, and an 80% reduction in porphobilinogen
deaminase activity to 0.0088 fmol uroporphyrin per 30 min per cell. Similar effects were evident in irradiated cells incubated with d-
aminolaevulinic acid immediately after, or following a 24 h interval, post-irradiation. There was little gain in efficacy from a second treatment
regimen applied within 24 h of the initial treatment, probably a result of initial metabolic damage leading to reduced levels of protoporphyrin
IX. These findings suggest that a correlation may exist between the d-aminolaevulinic acid induction of porphobilinogen deaminase activity
and the increase in intracellular protoporphyrin IX accumulation.
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presence of exogenous d-ALA (Gibson et al, 1998). Presently, we
extend those findings by examining the effect photosensitization
would have on PBGD activity and PPIX accumulation. The ques-
tions asked were: (1) are either PBGD activity or PPIX levels
altered following d-ALA-induced photosensitization?; (2) are
photosensitized cells able to synthesize PPIX?; and (3) can cells be
photosensitized with a second round of treatment?
Our results show that PBGD activity is inhibited by d-ALA-
induced photosensitization with a concomitant decrease in PPIX
levels. Subsequent treatment of these cells with light resulted in
reduced cytotoxicity, indicating that retreatment of lesions with
d-ALA-based PDT within 24 h after their initial exposure is
compromised due to the inability of the cells to synthesize PPIX.
MATERIALS AND METHODS
Chemicals and reagents
All chemicals and reagents were purchased from Sigma Chemical
Co. (St Louis, MO, USA) unless otherwise noted. Cell culture
media and antibiotics were obtained from Grand Island Biological
(Grand Island, NY, USA). Fetal bovine serum (FBS) was
purchased from Atlanta Biologicals (Atlanta, GA, USA). d-amino-
laevulinic acid (d-ALA) was obtained from Porphyrin Products
(Logan, UT, USA) and Cell TrackerTM was purchased from
Molecular Probes (Eugene, OR, USA).
Cells and culture conditions
The R3230AC cell line was established from R3230AC rodent
mammary adenocarcinomas. These tumours were maintained by
transplantation into the abdominal region of 100–120 g Fischer
female rats, using the sterile trochar technique described earlier
(Hilf et al, 1965). Cells were cultured from tumour homogenates
using the method of Hissin and Hilf (1978). Cells were maintained
in passage culture on 100 mm diameter polystyrene dishes (Becton
Dickinson, Franklin Lakes, NJ, USA) in 10 ml minimum essential
medium (a-MEM) plus phenol red supplemented with 10% FBS,
50 units ml–1 penicillin G, 50 mg ml–1 streptomycin and 1.0 mg ml–1
Fungizone® (‘complete a-MEM’). Depending on the experiment,
the medium was modified to fit desired conditions. In all cases, the
medium contained penicillin G, streptomycin and Fungizone®.
The modifications were made for cells incubated with d-ALA, a-
MEM without FBS containing phenol red (a-MEM–FBS+d-ALA);
or the irradiation procedure, a-MEM without FBS or phenol red or
d-ALA (a-MEM–FBS–phenol red–d-ALA). Only cells from
passages 1–10 were used for experiments. A stock of cells, from
passages 1–4, were stored at –86°C and used to initiate cultures.
Cultures were maintained at 37°C in a 5% carbon dioxide humidi-
fied atmosphere (Forma Scientific, Marietta, OH, USA). Passage
was accomplished by trypsinizing cells and seeding new dishes
with an appropriate number of cells in 10 ml of complete a-MEM.
Cell counts were performed using a particle counter (Model ZM,
Coulter Electronics, Hialeah, FL, USA).
Irradiation of cultured R3230AC cells incubated with
d-ALA
Five different experimental protocols were used to determine the
effects that d-ALA incubation plus or minus light exposure had on
PBGD activity, intracellular PPIX content and cell proliferation in
the cultured R3230AC cells (Figure 1). In Experiment 1, cells were
incubated in a-MEM–FBS+0.5 mM d-ALA in the dark for 27 h. At
Table 1 Effects of d-ALA-induced photosensitization on cell proliferation
and intracellular CellTrackerTM concentration
Day Cell number ´ 105 CellTrackerTM
1 4.97 ± 0.59 0.22 ± 0.05
2 (no light) 10.6 ± 1.60 0.10 ± 0.02
2 (30 mJ cm–2) 3.76 ± 0.41 0.23 ± 0.06
R3230AC cells were incubated with d-ALA and CellTrackerTM with or without
subsequent light exposure (see Materials and Methods). The data on Day 1
represent baseline values for cell number and CellTrackerTM fluorescence,
expressed as relative fluorescence units per cell, obtained prior to the
addition of d-ALA or irradiation of cultures. The data listed for day 2 were
obtained 24 h after cells were incubated for 3 h with d-ALA and either
exposed to 30 mJ cm–2 irradiation or maintained in the dark. Each value
represents the mean cell number or CellTrackerTM concentration calculated
from the results of at least three separate experiments performed in
duplicate, ± s.e.m.
Experiment 1
ALA 27 h
Experiment 2
ALA 3 h ALA 24 h
Experiment 3
ALA 24 h
Experiment 4
no ALA +FBS 24 h ALA 24 h
Experiment 5
ALA 3 h no ALA +FBS 24 h ALA 24 h
ALA 3 h
ALA 3 h
Figure 1 Graphic representation of the experiments employed to study the
effects of d-ALA administration and subsequent photoradiation on PPIX
levels and PBGD activity in cultured R3230AC cells. The horizontal boxes
are not drawn to the exact time scale, but represent the different time periods
in each experiment. Experiment 1: cells were incubated in a-MEM–FBS+d-
ALA in the dark for 27 h. Experiment 2: cells were incubated in a-
MEM–FBS+d-ALA for 3 h. The medium containing d-ALA was then removed,
a-MEM–FBS–phenol red–d-ALA was added for 2.5 min (boxes with *)
followed by a 24-h incubation in a-MEM–FBS+d-ALA. Experiment 4: cells
were incubated in a-MEM–FBS+d-ALA for 3 h, and the medium replaced with
a-MEM–FBS-phenol red–d-ALA for 2.5 min (box with *). Complete a-MEM
was added for 24 h, followed subsequently by a 24-h incubation in a-
MEM–FBS+d-ALA. Experiment 3 was similar to Experiment 2 except that
during the 2.5-min interval between d-ALA incubations, cultures were
exposed to 30 mJ cm–2 irradiation (shaded box). Experiment 5 was the same
as Experiment 4 except that cultures were exposed to 30 mJ cm–2 (shaded
box) after the initial 3-h d-ALA incubation period. At selected times during
each experiment, cells were removed for determination of PPIX levels,
PBGD activity and cell number1000 SL Gibson et al
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selected times during this incubation period, measurements of
PBGD and PPIX levels and cell counts were performed. Experiment
1 served as the baseline control for the various parameters measured,
being obtained from a single 27-h d-ALA incubation.
The second protocol, Experiment 2, consisted of incubation of
cultures with a-MEM–FBS+0.5 mM d-ALA for 3 h. The medium
containing  d-ALA was removed, a-MEM–FBS–phenol red–d-
ALA was added for 2.5 min (box with asterik, Figure 1) followed
by a 24-h incubation period in a-MEM–FBS+0.5 mM d-ALA. All
manipulations were performed in subdued room light, and incuba-
tions were carried out at 37°C in the dark. Experiment 2 served as
a control for the cells that were exposed to d-ALA and light, and to
ascertain whether the 2.5-min interval between d-ALA incubations
would affect any of the measured parameters when compared to
Experiment 1. The third protocol, Experiment 3, was similar to
Experiment 2 except that the 2.5-min interval after the initial d-
ALA incubation was used to expose cultures to 30 mJ cm–2 fluo-
rescent light (shaded box, Figure 1). The light, emitted from a 14
W fluorescent bulb was positioned 6 cm above the monolayers,
was delivered at a fluence rate of 0.2 mW cm–2. After irradiation,
cells were incubated in the dark in a-MEM–FBS+0.5 mM d-ALA
for 24 h. No interval between the end of the 2.5-min light or
dark, and the addition of the second course of d-ALA was chosen
to determine the immediate effects, if any, on the measured
parameters.
In the fourth protocol, Experiment 4, a 24-h dark incubation
period, during which cells were maintained in complete a-MEM,
was inserted between the initial 3-h d-ALA incubation time and a
subsequent 24-h d-ALA incubation period. Finally, Experiment 5
was the same as Experiment 4, except that cultures were exposed
to 30 mJ cm–2 in a-MEM–FBS–phenol red–d-ALA (shaded
box, Figure 1). After this 24-h incubation period, a-MEM–
FBS+0.5 mM d-ALA was added for 24 additional h. The 24-h
interval was added between d-ALA incubation periods to deter-
mine if during this time, repair of photosensitized damage might
occur. All determinations were made at selected times during the
incubation periods in each scheme.
Incubation of R3230AC cultures with CellTrackerTM
CellTrackerTM is a commercial reagent used to fluorescently label
cells as they proceed through cell division or are passed in culture.
Using this reagent, one is able to track labelled cells in culture and
in tissue. For our experiments, cultures were seeded and main-
tained as described above. The complete medium was removed,
1.0 ml of medium minus FBS plus 0.5 mM final concentration of
CellTrackerTM was added, and cells were incubated at 37°C for
45 min in the dark. The CellTrackerTM containing medium was
then removed, 1.0 ml of complete medium was added and cultures
were incubated at 37°C for an additional 30 min. The complete
medium was then removed and 0.5 mM d-ALA in medium–FBS
was added as described above.
Measurement of porphyrin or CellTrackerTM
fluorescence in cultured cells
The extent of porphyrin biosynthesis induced by d-ALA was
determined by measuring the porphyrin fluorescence intensity
in cell digests. At selected times during the incubation periods
described above, the medium was removed, cells were washed
once in medium minus FBS and 1.0 ml of 25% Scintigest® was
added, thereby detaching cells from the surface within 5 min. The
cell suspensions were transferred to 12 ´ 75-mm glass tubes,
capped with parafilm and placed in a 37°C water bath for 1.0 h.
Cell digests were then stored at –20°C until fluorescence measure-
ments were made. Samples were removed from storage, thawed at
room temperature, brought to a final volume of 2.0 ml with 1.0 ml
25% Scintigest® and mixed vigorously. Samples were then trans-
ferred to a quartz cuvette which was positioned in a spectro-
fluorimeter (Fluorolog 2, SPEX Industries, Edison, NJ, USA).
Excitation was at 400 nm, and the fluorescence emission was
scanned from 600 to 720 nm. Two distinct peaks were detected at
630 and 704 nm, with maximum fluorescence at 630 nm. The 630-
nm peak was selected for measurement of intracellular porphyrin.
Background autofluorescence, which represented 5% or less of the
fluorescence signal at 630 nm, was determined in cells that had not
been exposed to d-ALA, and those values were subtracted from
those obtained for cells exposed to d-ALA. Intracellular porphyrin
content was calculated using a reference PPIX standard dissolved
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Figure 2 Levels of intracellular PPIX measured in cultured R3230AC cells
incubated over time in the presence of 0.5 mM d-ALA. The data in Figure 2
were obtained using 5 different experimental protocols (refer to Figure 1).
(A) The PPIX levels, expressed as mols PPIX per cell, obtained from cells
exposed to Experiment 1 (n n), Experiment 2 (l), or Experiment 4 (l l). The
data in (B) were obtained from experiments in which cells were exposed to
either Experiment 1 (n n), Experiment 3 (s), or Experiment 5 (s s) conditions.
Each data point represents 4–7 separate determinations performed in
duplicate, the bars are the s.e.m.d-Aminolaevulinic acid-induced photosensitization 1001
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in Scintigest®. Addition of the reference PPIX standard to
Scintigest® containing digested cells not exposed to d-ALA did
not alter the fluorescent signal from that observed for the cell-free
PPIX standard. Data are expressed as mol of fluorescent porphyrin
per cell.
CellTrackerTM, Green CMFDA (5-chloromethylfluorescein
diacetate) reagent, was incubated with cells, as described above.
Once taken up into the cells, the CellTrackerTM reagent is thought
to undergo a glutathione-S-transferase-mediated reaction resulting
in a cell-impermeant fluorescent product. Cells containing
CellTrackerTM were prepared for fluorescence measurements in
Scintigest® as described for porphyrin determinations. Excitation
of the CellTrackerTM/cell digest at 490 nm resulted in a single
fluorescence emission peak at 540 nm and was not effected by the
presence of PPIX in the cells. Intracellular fluorescence of
CellTrackerTM is expressed as relative fluorescence units per cell.
Measurement of PBGD activity in cultured R3230AC
cells
The activity of PBGD is measured by the absorbance of uropor-
phyrin, formed after light-induced oxidation of uroporphyrinogen,
the immediate product of the enzymatic deamination reaction
according to Grandchamp et al (1976). Briefly, cultured cells were
removed with trypsin at selected times during incubations as
described above, then transferred to 15-ml conical tubes and
centrifuged at 1000 g for 5 min. Supernatants were discarded and
0.5 ml of distilled deionized water was added to the pellets and
vigorously mixed. Cell suspensions were then sonicated using a
Branson Sonicator (Model 185) at a setting of 4 for 5 s.
Microscopic inspection showed that > 90% of the cells were
disrupted by this procedure.
The cell lysates were centrifuged at 3000 g for 15 min and the
collected supernatant was centrifuged at 10 000 g for 15 min. A
portion of the supernatant containing 2 mg protein was incubated
for 30 min at 45°C in the dark with 0.1 ml porphobilinogen (PBG),
1.0 mM final concentration. The reaction was stopped by addition
of 2.0 ml ethyl acetate/acetic acid (3:1, v/v). The mixture was then
centrifuged at 3000 g for 10 min, followed by exposure of samples
to ambient light at room temperature for 15 min. Then, 1.6 ml of
the porphyrin-containing upper layer were mixed with 1.0 ml of
0.5 M hydrochloric acid, followed by centrifugation at 300 g for
10 min. The supernatant was removed and fluorescence measure-
ments were performed on the lower layer containing the uropor-
phyrin. One millilitre of this layer was mixed with an equivalent
amount of 0.05 M phosphate-buffered saline (PBS), pH 7.1.
Excitation at 405 nm resulted in a fluorescence emission peak at
650 nm. Uroporphyrin content in these samples was calculated by
reference to a uroporphyrin standard dissolved in PBS. Data are
expressed as fmol uroporphyrin per cell.
Determination of cell proliferation
To determine the effect of irradiation on the proliferative capacity
of cells exposed to d-ALA, the following experiments coincident
with determinations of porphyrin, PBGD and CellTrackerTM levels
were performed.
At selected d-ALA incubation periods in each experiment, the
medium was removed, 0.2 ml trypsin solution was added to each
well and plates were incubated at 37°C until the cells lifted off the
surface (approximately 5 min). Cell counts were performed using
a particle counter (Model ZM, Coulter Electronics, Hialeah, FL,
USA) and cell numbers from irradiated wells were compared with
those from wells not exposed to light. For example, cell numbers
obtained at the end of Experiment 3 were compared to values for
Experiment 2.
In another series of experiments, the effects on cytotoxicity of a
subsequent irradiation period in cultures previously exposed to
d-ALA and light were determined. These experiments were
performed using two additional treatment regimens. In the first,
after completion of all the procedures in Experiment 3, cells
remaining on the plate were washed, a-MEM–FBS–phenol red–d-
ALA was added and cultures were re-exposed to 30 mJ cm–2 light.
Immediately after irradiation, complete a-MEM was added for
24 h and cell counts were obtained as above at the end of this incu-
bation period. The same approach was used on cultures treated in
Experiment 5. At the end of Experiment 5, cells were exposed to
30 mJ cm–2, the medium was changed, complete a-MEM was
added and cells were counted 24 h later as described above. The
results obtained were compared to those experiments in which
cells were not irradiated for a second time but had been subjected
to either Experiment 2 or Experiment 4 respectively.
Statistical analysis
Statistical analyses were performed using the Student’s t-test. For
all tests, a two-sided P-value of less than 0.05 was considered to be
a statistically significant difference.
RESULTS
Effect of irradiation on d-ALA-induced PPIX levels in
vitro
The data displayed in Figure 2A demonstrate that PPIX levels
in cultured R3230AC cells using Experiment 1 conditions, i.e.
incubation with 0.5 mM d-ALA for 24 h, were equivalent to that
produced by cells exposed to the conditions of Experiment 2 or
Experiment 4. Cells collected at the end of Experiment 1 contained
6.07 ± 0.73 ´ 10–16 mol PPIX per cell (mean ± s.e.m.), whereas cells
from Experiment 2 and Experiment 4 had levels of 6.15 ± 0.74
´ 10–16 mol and 5.26 ± 0.53 ´ 10–16 mol PPIX per cell respectively.
The data displayed in Figure 2B show that illumination of mono-
layer cultures using Experiment 3 or Experiment 5 regimens signi-
ficantly impaired the cells’ ability to synthesize PPIX after
exposure to 0.5 mM d-ALA. A 60% reduction in intracellular PPIX
was observed in cultures 24 h after exposure to 30 mJ cm–2 irradia-
tion. The reduction in cellular PPIX content was comparable for
both Experiment 3 and Experiment 5, where 2.28 ± 0.26 ´ 10–16 mol
and 1.53 ± 0.31 ´ 10–16 mol of PPIX were measured respectively.
Effect of irradiation on d-ALA-induced PBGD activity
in vitro
Concurrent experiments were performed to determine the effects
of these treatment schemes on PBGD activity. Figure 3A displays
data obtained from cells incubated with d-ALA under Experiment
1 and Experiment 2, or Experiment 4 conditions. The PBGD
activity after a single 24-h incubation with 0.5 mM d-ALA
(Experiment 1) was 0.046 ± 0.005 fmol uroporphyrin produced
per cell. Similar PBGD activities were measured in cells from
Experiment 2, 0.037 ± 0.005 fmol uroporphyrin produced per cell,1002 SL Gibson et al
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and cells from Experiment 4, 0.034 ± 0.005 fmol uroporphyrin per
cell.
Exposing cell cultures to 30 mJ cm–2 irradiation under the condi-
tions described for Experiment 3 or Experiment 5 resulted in
significant inhibition of the increase in PBGD activity observed in
Experiment 1. Enzyme activity in cultures exposed to Experiment
3 was reduced to 0.0088 ± 0.0017 fmol uroporphyrin per cell and
to 0.018 ± 0.0019 fmol uroporphyrin per cell in those cells treated
under the Experiment 5 regimen.
Effect of irradiation on intracellular CellTrackerTM
concentration and cell proliferation
Under our standard culture conditions, i.e. complete a-MEM,
R3230AC cells double every 24 h (Table 1). Exposure to 0.5 mM
d-ALA for 3 h, followed immediately by 30 mJ cm–2 irradiation,
prevented the expected increase in cell number at 24 h, with cell
numbers being equivalent to those at the start of the experiment.
The manufacturer (Molecular Probes Inc.) states that
CellTrackerTM is taken up by cells equally, independent of cell
cycle etc., and is distributed uniformally amongst daughter cells
during cell division. The data in Table 1 demonstrate this to be the
case for cultured R3230AC cells. For untreated cells that doubled
in number over 24 h, concomitantly, the amount of CellTrackerTM
per cell was halved. However, 24 h after 3-h incubation with
0.5 mM d-ALA and exposure to 30 mJ cm–2 irradiation, the intra-
cellular concentration of CellTrackerTM remained the same as it
was prior to photosensitization (Table 1). These data suggest that
the majority of cells examined 24 h after treatment with d-ALA
and light had not proliferated.
Cytotoxicity following a second exposure to
d-ALA-induced photosensitization
The effects that a second exposure to d-ALA-induced photosensi-
tization had on cell viability were determined (Table 2). Initially,
exposure of cells to 0.5 mM d-ALA for 3 h, followed by irradiation
at 30 mJ cm–2, resulted in a modest decrease in cell number
(P > 0.1) from 3.25 ± 0.26  ´ 105 cells prior to irradiation to
2.48  ± 0.3 ´ 105 cells 24 h after irradiation. When 30 mJ cm–2 irra-
diation was delivered to cultures at the end of the d-ALA incuba-
tions in Experiment 3 or Experiment 5, the cell numbers declined
further to 1.12 ± 0.17 ´ 105 and 0.68 ± 0.53 ´ 105 cells, respec-
tively, at 24 h after irradiation. However, the decreases in cell
number after the second irradiation were not significantly different
from the lower cell numbers observed for Experiment 2, 1.29 ±
0.15 ´ 105 cells, or Experiment 4, 0.99 ± 0.13 ´ 105, when the cells
were not exposed to a second irradiation cycle.
DISCUSSION
The goal of cancer treatment is the eradication of all malignant
cells. One method frequently employed is sequential treatment
delivery. Multiple therapeutic courses are delivered, with the
expectation that each subsequent course will destroy at least one
log order of cells. Such regimens might be considered for PDT.
Previously, we examined the effectiveness of Photofrin®-based
PDT on the growth of transplantable rodent mammary tumours
treated at a time after their original transplantation or as tumours
that recurred after an initial round of PDT (Gibson et al, 1995). We
Table 2 Cytotoxic effects of a second application of d-ALA-induced
photosensitization on cultured R3230AC cells
Treatment Cell number ´105
1. Control (before hv) 3.25 ± 0.26
2. Experiment 1 2.48 ± 0.30
3. Experiment 2 1.29 ± 0.15
4. Experiment 3 1.12 ± 0.17
5. Experiment 4 0.99 ± 0.13
6. Experiment 5 0.68 ± 0.053
Cell numbers were determined 24 h after the end of each treatment (see
Materials and Methods for experimental details). Treatments were: (1) cell
number after 3-h incubation with 0.5 mM d-ALA prior to 2.5 min irradiation;
(2) cell number 27 h after Experiment 1; (3) cell number 24 h after
Experiment 2 without a second irradiation period; (4) cell number 24 h after
Experiment 3 plus a second irradiation period immediately following
Experiment 3; (5) cell number after Experiment 4 without a second irradiation
period; (6) cell number after Experiment 5 plus a second irradiation period
following Experiment 5. Cell numbers are presented as the mean of at least
three separate experiments performed in duplicate ± s.e.m.
Figure 3 Levels of PBGD activity in cultured R3230AC cells measured
during incubation with 0.5 mM d-ALA. The data in Figure 2 were obtained
using five different experimental protocols (refer to Figure 1). (A) The PBGD
levels obtained from cells exposed to Experiment 1 (n n), Experiment 2 (l) or
Experiment 4 (l l). The data in (B) were obtained from experiments in which
cells were exposed to either Experiment 1 (n n), Experiment 3 (s) or
Experiment 5 (s s) conditions. The data are expressed as fmol uroporphyrin
produced per cell 30 min–1. Each data point represents at least 4–7 separate
determinations performed in duplicate, the bars are the s.e.m.
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found that the second course of treatment was just as effective in
controlling tumour growth as the first regimen. We also discovered
that Photofrin® accumulation and subsequent phototoxicity was
equivalent in cells isolated from either original or recurrent
tumours. The results of those studies demonstrated that the cells
surviving the first course of PDT did not develop any detectable
resistance when exposed to an additional cycle of PDT. We
suggested that a multiple therapeutic regimen might be employed
for more than one cycle leading to enhanced treatment success.
However, one major drawback to this scheme is that skin photo-
sensitivity might be prolonged considerably if replicative treat-
ments with Photofrin® are used.
In this report, we examine whether d-ALA-based PDT can be
applied successfully for more than one therapeutic cycle. One
advantage of d-ALA-induced PPIX production over exogenous
photosensitizer administration is that PPIX does not remain in the
skin for prolonged periods of time. Soon after the clearance of
d-ALA from the system, production and accumulation of PPIX
rapidly decline, resulting in little latent photosensitivity. However,
in contrast to Photofrin®, PDT using d-ALA-induced photosensi-
tization presents additional pharmacokinetic considerations. One
problem is that different cell types, normal or malignant, do not
respond equally to the exogenous administration of d-ALA. This
could result in less than sufficient levels of PPIX being formed in
desired target tissues. Additionally, the effectiveness of a second
course of PDT using d-ALA is dependent on the presence of a
fully functional haem biosynthetic pathway.
We investigated these questions, in vitro, by exposing cultured
R3230AC rat mammary adenocarcinoma cells to d-ALA and light
and measuring the effects on PBGD activity, intracellular PPIX
levels and cell proliferation. A second course of therapy was subse-
quently applied and its efficacy was assessed by determining cell
proliferation. The results demonstrated that PBGD activity and PPIX
levels were reduced concomitantly by the first course of d-ALA-
induced photosensitization. As expected, this limited the cells’
biosynthetic capabilities to form additional PPIX, causing a signifi-
cant decrease in efficacy when the second round of treatment was
applied to previously treated cells. The reduced efficacy was evident
for regimens with no interval between treatment cycles in
Experiment 3, or with 24 h intervening between treatment courses in
Experiment 5. We selected these two treatment regimens to deter-
mine whether the effects observed immediately after irradiation
would persist, or if repair processes might restore haem biosynthesis.
The results suggest that the damage that occurs immediately after
irradiation persists for at least 24 h, as evidenced by the dramatic
reduction in PPIX accumulation. The inability of cells to repair the d-
ALA-induced damage was reflected by the reduced cytotoxicity
observed after a second round of irradiation was applied. Cell counts,
performed 24 h after a second irradiation, were only reduced by
10–13% compared to their unirradiated counterparts. The data also
show that both PBGD and PPIX levels were reduced by d-ALA-
induced photosensitization using either Experiment 3 or Experiment
5 conditions. These results lend support to the hypothesis that PBGD
is a most important enzyme target when d-ALA is administered
exogenously (Gibson et al, 1998).
Our data, however, are in contrast with results obtained earlier by
He et al (1993, 1995). In two separate studies they reported increased
levels of PPIX in either A431 human epidermal carcinoma cells or
transformed human microvascular endothelial cells at 2–48 h after
irradiation of cultures in the presence of d-ALA-induced PPIX.
Ferrochelatase, the last enzyme in the haem biosynthetic pathway,
catalyses the formation of haem, a non-photosensitizer, by metalla-
tion of PPIX with iron. The above reports stated that ferrochelatase
activity was inhibited, attributing the increase in PPIX to a reduced
ability to metallate PPIX. The difference between their data and ours
might be attributed to the use of different cell types and experimental
conditions. One difference is that they used confluent cultures
exposed to d-ALA and light while we performed experiments with
cells in log phase growth. According to earlier reports (Washbrook et
al, 1997; Wyld et al, 1997; Moan et al, 1998) and our unpublished
results, d-ALA uptake, PPIX accumulation and PBGD activity are
dependent on cell type and cell density. This latter phenomenon
could be a major confounding factor in comparisons of data obtained
by different groups.
On the other hand, van der Veen et al (1994) reported that a
transplantable tumour treated with d-ALA-based PDT displayed
PPIX levels that were reduced to below background immediately
after irradiation. Ninety minutes later, PPIX fluorescence re-
appeared in the tumours at half the level observed prior to the initial
light exposure. They attributed these events to PPIX photo-
bleaching during the first light exposure followed by resynthesis of
PPIX prior to the second irradiation cycle. Those data are similar to
ours, but their attribution that disappearance of PPIX fluorescence
is entirely due to photobleaching is speculative. They reported that
their first course of therapy altered the structural integrity of the
tumours, results suggesting that the damaged cells might release
PPIX into the extracellular space where it could be transported
from the tumour site. This occurrence by itself could contribute to
the apparent loss in porphyrin fluorescence. In our experiments in
vitro, we did not detect a reduction in porphyrin fluorescence
immediately after irradiation, essentially ruling out photobleaching.
Thus, the reduced fluorescence we see 24 h after irradiation is
likely due to the inability of cells to synthesize PPIX, a hypothesis
supported by the data showing inhibition of PBGD activity.
The results obtained here, taken together with earlier reports,
demonstrate that d-ALA-induced porphyrin biosynthesis, and the
effect that irradiation has on this process, is quite complicated. Our
data demonstrate that one component of the haem biosynthetic
pathway, PBGD, is sensitive to PPIX photosensitization. We also
show an apparent association between inhibition of this enzyme and
reduction in PPIX synthesis. Finally, these results suggest that if
lesions are re-treated with d-ALA-induced PDT within the first 24 h
after initial therapy, the subsequent treatment efficacy would be
compromised by the diminished ability of cells to synthesize PPIX.
We plan to examine this hypothsis in vivo and to continue to measure
the haem biosynthetic pathway to determine whether any other key
control points are affected by d-ALA-induced photosensitization.
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